Comparison of Ketanserin and Metoprolol in the Treatment of Essential Hypertension
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
SAS user's guide
1979 • 7,396 citations
Serotonin and the cardiovascular system
1985 • 143 citations
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.
1982 • 90 citations
Ketanserin, a novel 5‐hydroxytryptamine antagonist: monotherapy in essential hypertension.
1983 • 64 citations
The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly Patients
1981 • 58 citations
Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist
1984 • 57 citations
Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.
1984 • 47 citations
Antihypertensive properties of ketanserin (R 41 468).
1983 • 36 citations
Effect of the 5‐hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin‐angiotensin system and sympatho‐adrenal function in patients with essential hypertension.
1984 • 25 citations
Bioavailability and pharmacokinetics of ketanserin in elderly subjects
1985 • 20 citations
Ketanserin in combination with beta‐adrenergic receptor blocking agents in the treatment of essential hypertension.
1984 • 19 citations
Long-term Effects on Central Haemodynamics and Body Fluid Volumes of Ketanserin in Essential Hypertension Studies at Rest and during Dynamic Exercise
1983 • 16 citations
Review of the use of alpha-adrenoceptor antagonists in hypertension.
1984 • 13 citations
The Effect of Ketanserin on Blood Pressure and Biochemical Parameters in Treated Patients with Essential Hypertension
1984 • 11 citations
Experience With Ketanserin, A Serotonin (S2) Antagonist, in Longterm Treatment of Essential Hypertension
1984 • 11 citations
Cited By (0)
No citing papers found in database